Meta and Chips Cover Up Market Weakness
Here are a few names I’m watching closely as we work through this difficult period.
Here are a few names I’m watching closely as we work through this difficult period.
Chips and software rally while the rest of the market struggles.
I reduced three biotech winners, and not because I think they are going down.
It’s time to change strategy as earnings season closes and seasonal weakness creeps in.
These small-cap biotechs offer core businesses that fund a much bigger opportunity.
Earnings growth better than 50%, a forward multiple around 12 and an analyst target roughly a third higher.
Dislocations driven by market conditions rather than fundamentals are creating my shopping list.
I’ve been expecting a little oversold rally, but not with this level of concern.
A classic Monday morning bull trap has snapped, and selling pressure is ramping up again.
Here’s what bothers me most about this market and four names I’m eyeing on pullbacks.